Auriga is keeping their Buy rating on Thermo Fisher Scientific (NYSE: TMO) as the company announces their acquisition with Dionex ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE